Sonoma Pharmaceuticals - 19 Year Stock Price History | SNOA

Historical daily share price chart and data for Sonoma Pharmaceuticals since 2007 adjusted for splits and dividends. The latest closing stock price for Sonoma Pharmaceuticals as of January 16, 2026 is 3.29.

The all-time high Sonoma Pharmaceuticals stock closing price was 69300.00 on July 18, 2007.
The Sonoma Pharmaceuticals 52-week high stock price is 6.92, which is 110.3% above the current share price.
The Sonoma Pharmaceuticals 52-week low stock price is 1.75, which is 46.8% below the current share price.
The average Sonoma Pharmaceuticals stock price for the last 52 weeks is 3.39.

Sonoma Pharmaceuticals Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	3.5436	3.6400	3.8000	3.2700	3.2900	-9.62%
2025	3.3500	2.6800	5.3500	1.8800	3.6400	35.32%
2024	3.6816	3.6000	8.6000	2.5300	2.6900	-25.28%
2023	18.0240	25.4000	40.4000	2.8000	3.6000	-83.93%
2022	57.5610	96.8000	96.8000	20.2000	22.4000	-75.44%
2021	136.8230	146.2000	192.8000	86.4000	91.2000	-37.19%
2020	131.9921	91.0000	196.0000	74.2000	145.2000	66.51%
2019	133.0310	138.6000	194.4000	78.8000	87.2000	-31.77%
2018	507.1984	1045.8000	1045.8000	117.0000	127.8000	-86.97%
2017	1083.4853	925.2000	1425.6000	750.6000	981.0000	8.13%
2016	841.4714	1035.0000	1233.0000	658.8000	907.2000	-12.35%
2015	1011.7857	1260.0000	1647.0000	630.0000	1035.0000	-19.58%
2014	2548.7143	3348.0000	5256.0000	1260.0000	1287.0000	-58.91%
2013	3133.6429	4032.0000	5400.0000	2079.0000	3132.0000	-18.50%
2012	5741.0640	7182.0000	8820.0000	3276.0000	3843.0000	-41.90%
2011	10687.2500	10962.0000	14175.0000	6174.0000	6615.0000	-37.87%
2010	11917.5000	11277.0000	16947.0000	9009.0000	10647.0000	-7.65%
2009	12574.2500	9387.0000	30933.0000	5670.0000	11529.0000	27.97%
2008	19696.8379	26334.0000	43092.0000	2520.0000	9009.0000	-65.12%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.006B	$0.014B
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$88.265B	33.53
Zoetis (ZTS)	United States	$55.210B	19.76
Takeda Pharmaceutical (TAK)	Japan	$51.962B	10.60
Daiichi Sankyo, - (DSNKY)	Japan	$40.823B	20.33
BeOne Medicines - (ONC)	Switzerland	$37.098B	196.68
Sandoz Group AG (SDZNY)	Switzerland	$33.290B	0.00
United Therapeutics (UTHR)	United States	$20.322B	17.89
Merck (MKKGY)	Germany	$19.406B	11.96
Shionogi (SGIOY)	Japan	$15.632B	14.36
Summit Therapeutics (SMMT)	United States	$13.318B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.296B	31.90
IPSEN (IPSEY)	France	$13.109B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.506B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.262B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.376B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$6.360B	35.59
Grifols, S.A (GRFS)	Spain	$6.140B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$5.355B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.146B	19.69
Indivior (INDV)	United States	$4.111B	16.78
Corcept Therapeutics (CORT)	United States	$3.723B	40.22
NewAmsterdam Pharma (NAMS)	Netherlands	$3.609B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.011B	0.00
Hypermarcas (HYPMY)	Brazil	$2.958B	20.30
Catalyst Pharmaceuticals (CPRX)	United States	$2.822B	9.00
Ocular Therapeutix (OCUL)	United States	$2.403B	0.00
Dyne Therapeutics (DYN)	United States	$2.345B	0.00
Soleno Therapeutics (SLNO)	United States	$2.253B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.960B	23.23
Guardian Pharmacy Services (GRDN)	United States	$1.868B	35.98
Harrow (HROW)	United States	$1.796B	110.21
Ardelyx (ARDX)	United States	$1.711B	0.00
Oruka Therapeutics (ORKA)	United States	$1.573B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$1.511B	89.62
Enliven Therapeutics (ELVN)	United States	$1.494B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.485B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.483B	7.34
Relay Therapeutics (RLAY)	United States	$1.322B	0.00
Evotec AG (EVO)	Germany	$1.285B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.230B	0.00
Savara (SVRA)	United States	$1.196B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.096B	0.00
Theravance Biopharma (TBPH)	United States	$1.019B	42.79
Cronos Group (CRON)	Canada	$0.990B	0.00
Xencor (XNCR)	United States	$0.943B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.756B	0.00
Esperion Therapeutics (ESPR)	United States	$0.748B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.735B	17.39
Nektar Therapeutics (NKTR)	United States	$0.719B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.686B	6.12
Bioventus (BVS)	United States	$0.661B	13.54
ProKidney (PROK)	United States	$0.656B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.547B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.512B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.508B	0.00
Organogenesis (ORGO)	United States	$0.504B	0.00
Lyell Immunopharma (LYEL)	United States	$0.487B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.48
Altimmune (ALT)	United States	$0.442B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.435B	0.00
Aquestive Therapeutics (AQST)	United States	$0.407B	0.00
Nature's Sunshine Products (NATR)	United States	$0.396B	23.58
USANA Health Sciences (USNA)	United States	$0.395B	11.02
Akebia Therapeutics (AKBA)	United States	$0.356B	0.00
Profound Medical (PROF)	Canada	$0.303B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.298B	0.00
Avalo Therapeutics (AVTX)	United States	$0.290B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.289B	0.00
Relmada Therapeutics (RLMD)	United States	$0.279B	0.00
OmniAb (OABI)	United States	$0.276B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Fractyl Health (GUTS)	United States	$0.270B	0.00
Larimar Therapeutics (LRMR)	United States	$0.270B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.265B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.263B	0.00
Protara Therapeutics (TARA)	United States	$0.260B	0.00
Journey Medical (DERM)	United States	$0.227B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.222B	0.00
Galectin Therapeutics (GALT)	United States	$0.203B	0.00
Century Therapeutics (IPSC)	United States	$0.201B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.194B	0.00
MediWound (MDWD)	Israel	$0.193B	0.00
Minerva Neurosciences (NERV)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
AleAnna (ANNA)	United States	$0.173B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.156B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.143B	0.00
Context Therapeutics (CNTX)	United States	$0.140B	0.00
Prelude Therapeutics (PRLD)	United States	$0.135B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.135B	0.00
Incannex Healthcare (IXHL)	Australia	$0.132B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.124B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.122B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.122B	0.00
Pyxis Oncology (PYXS)	United States	$0.115B	0.00
Avita Medical (RCEL)	United States	$0.106B	0.00
Cassava Sciences (SAVA)	United States	$0.103B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.19
Cardiol Therapeutics (CRDL)	Canada	$0.096B	0.00
Vivani Medical (VANI)	United States	$0.092B	0.00
Korro Bio (KRRO)	United States	$0.083B	0.00
Gain Therapeutics (GANX)	United States	$0.072B	0.00
Assertio Holdings (ASRT)	United States	$0.071B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.071B	59.50
PolyPid (PYPD)	Israel	$0.070B	0.00
Dominari Holdings (DOMH)	United States	$0.067B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Metagenomi (MGX)	United States	$0.063B	0.00
Lipocine (LPCN)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.061B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.059B	0.00
ElectroCore (ECOR)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Lite Strategy (LITS)	United States	$0.051B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.047B	0.00
Talphera (TLPH)	United States	$0.046B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.039B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.037B	0.00
Wellgistics Health (WGRX)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.030B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.023B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.020B	0.00
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.017B	0.00
Mannatech (MTEX)	United States	$0.017B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Traws Pharma (TRAW)	United States	$0.014B	0.02
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00